Monitoring treatment response in EGFR mutant non-small cell lung cancer patients using mutational load in circulating cell-free tumour DNA.

e19089 Background: The identification of activating EGFR mutations is essential for deciding therapy of non-small cell lung cancer (NSCLC) patients. Although evaluation of tumour biopsy material is...